Altman Advisors, Inc. Novo Nordisk A S Transaction History
Altman Advisors, Inc.
- $204 Million
- Q1 2024
A detailed history of Altman Advisors, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Altman Advisors, Inc. holds 15,930 shares of NVO stock, worth $2.1 Million. This represents 1.0% of its overall portfolio holdings.
Number of Shares
15,930
Previous 15,469
2.98%
Holding current value
$2.1 Million
Previous $1.6 Million
27.81%
% of portfolio
1.0%
Previous 0.84%
Shares
3 transactions
Others Institutions Holding NVO
# of Institutions
1,883Shares Held
310MCall Options Held
5.36MPut Options Held
4.95M-
Jennison Associates LLC21.1MShares$2.77 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.81 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.72 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.58 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.55 Billion4.6% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $297B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...